Search results for "Pulmonary angiography"

showing 10 items of 12 documents

Hemodynamic Effects of Nonionic Contrast Bolus Injection and Oxygen Inhalation During Pulmonary Angiography in Patients With Chronic Major-Vessel Thr…

1996

Background Pulmonary angiography is the gold standard for the diagnosis of chronic thromboembolic pulmonary hypertension; however, major complications have been reported. This study evaluates the hemodynamic effects of direct pulmonary nonionic contrast bolus injection and oxygen inhalation in patients with chronic thromboembolic pulmonary hypertension. Methods and Results In 33 patients, hemodynamic parameters were measured after oxygen inhalation and during bolus injection of nonionic contrast medium in a control group (group 1, n=11), in a group of patients with moderately severe pulmonary hypertension (group 2, n=9), and in a group with severe pulmonary hypertension (group 3, n=13). Ox…

AdultMalePulmonary CirculationHypertension PulmonaryContrast MediaInjectionsPulmonary heart diseaseThromboembolismPhysiology (medical)medicine.arteryAdministration InhalationmedicinePulmonary angiographyHumansAgedmedicine.diagnostic_testInhalationbusiness.industryRespiratory diseaseHemodynamicsAngiography Digital SubtractionMiddle Agedmedicine.diseasePulmonary hypertensionOxygenmedicine.anatomical_structureAnesthesiaAngiographyPulmonary arteryVascular resistanceFemaleCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection

2021

Summary Objective To determine the incidence, characteristics, and risk factors of pulmonary embolism (PE) among patients hospitalized for COVID-19. Patients and Methods We performed a prospective observational study of a randomly selected cohort of consecutive patients hospitalized for COVID-19 infection between March 8, 2020 through April 25, 2020. All eligible patients underwent a computed tomography pulmonary angiography independently of their PE clinical suspicion and were pre-screened for a baseline elevated D-dimer level. Results 119 patients were randomly selected from the 372 admitted to one tertiary hospital in Valencia (Spain) for COVID-19 infection during the period of study. Se…

Male0301 basic medicineCTPA Computed tomography pulmonary angiographyAUC-ROC Area under curve ROCPCR polymerase chain reaction0302 clinical medicineRisk FactorsspO2 Oxygen saturationIL6 Interleukin-6Pulmonary angiographySD Standard deviationMedicineProspective Studies030212 general & internal medicineProspective cohort studyComputed tomographyFramingham Risk ScoreIncidenceIncidence (epidemiology)RV Right ventricleHazard ratioVenous ThromboembolismMiddle AgedAo Aortic arteryPulmonary embolismCXR chest X-rayHospitalizationInfectious DiseasesCohortCRP C-reactive proteinFemalePA Pulmonary artery trunkMicrobiology (medical)medicine.medical_specialty030106 microbiologysPESI Simplified Pulmonary Embolism Severity IndexBMI Body mass indexPE Pulmonary embolismLV Left ventricleVTE Venous thromboembolismFibrin Fibrinogen Degradation Products03 medical and health sciencesInternal medicineHumansICU Intensive care unitsACE2 Angiotensin converting enzyme-2AgedInflammationLDH Lactate dehydrogenaseSARS-CoV-2 Severe acute respiratory syndrome coronavirus 2CI Confidence intervalbusiness.industryPulmonary embolismCOVID-19AnticoagulantsThrombosisRR Respiratory ratemedicine.diseaseConfidence intervalCHOD CRP concentration + Heart rate + Oxygen saturation + D-dimer levelsSpainHR Hazard RatioCommentarybusinessJournal of Infection
researchProduct

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

2020

Background Few data are available on the rate and characteristics of thromboembolic complications in hospitalized patients with COVID-19. Methods We studied consecutive symptomatic patients with laboratory-proven COVID-19 admitted to a university hospital in Milan, Italy (13.02.2020–10.04.2020). The primary outcome was any thromboembolic complication, including venous thromboembolism (VTE), ischemic stroke, and acute coronary syndrome (ACS)/myocardial infarction (MI). Secondary outcome was overt disseminated intravascular coagulation (DIC). Results We included 388 patients (median age 66 years, 68% men, 16% requiring intensive care [ICU]). Thromboprophylaxis was used in 100% of ICU patients…

MaleComorbidity030204 cardiovascular system & hematologyBrain Ischemia0302 clinical medicineHospitals UrbanPatient AdmissionRisk FactorsPulmonary angiographyAmbulatory CareThrombophiliaCardiovascular complicationsMyocardial infarctionHospital MortalityAged 80 and overHematologyMiddle AgedPulmonary embolismItaly030220 oncology & carcinogenesisAmbulatoryFemaleCoronavirus InfectionsVenous thromboembolismmedicine.medical_specialtyAcute coronary syndromeCritical CarePneumonia ViralArterial Occlusive DiseasesDisseminated intravascular coagulationThrombophiliaArticle03 medical and health sciencesInternal medicineIntensive caremedicineHumansAcute Coronary SyndromeMortalityHospitals TeachingPandemicsAgedRetrospective Studiesbusiness.industryCoronary ThrombosisAnticoagulantsCOVID-19Retrospective cohort studyLength of Staymedicine.diseaseSARS-CoV2businessPulmonary EmbolismThrombosis Research
researchProduct

Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review an…

2018

Abstract Aims Patients with acute pulmonary embolism (PE) classified as low risk by the Pulmonary Embolism Severity Index (PESI), its simplified version (sPESI), or the Hestia criteria may be considered for early discharge. We investigated whether the presence of right ventricular (RV) dysfunction may aggravate the early prognosis of these patients. Methods and results We did a systematic review and meta-analysis of studies including low-risk patients with acute PE to investigate the prognostic value of RV dysfunction. Diagnosis of RV dysfunction was based on echocardiography or computed tomography pulmonary angiography. In addition, we investigated the prognostic value of elevated troponin…

MaleComputed Tomography AngiographyVentricular Dysfunction Right030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineNatriuretic peptidePulmonary angiographyHospital MortalityRight ventricular dysfunctionAged 80 and overbiologyMortality rateHome treatmentMiddle AgedPrognosisTroponinPulmonary embolismEchocardiographyMeta-analysisAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtymedicine.drug_classFast Track Clinical ResearchRisk Assessment03 medical and health sciencesAnticoagulationInternal medicinemedicineHumansMortalityNatriuretic PeptidesRisk stratificationAgedbusiness.industryPulmonary embolismAnticoagulants030229 sport sciencesOdds ratiomedicine.diseaseTroponinConfidence intervalEditor's Choicebiology.proteinbusinessBiomarkersEuropean Heart Journal
researchProduct

Progress in the management of acute pulmonary embolism.

2015

Purpose of review Pulmonary embolism is a major contributor to global disease burden worldwide. The 2014 guidelines of the European Society of Cardiology, endorsed by the European Respiratory Society, emphasize the need for initial and advanced risk stratification as well as risk-adapted treatment to ensure the highest quality of care. This review summarizes the progress in pulmonary embolism diagnosis, risk assessment, and treatment. Recent findings Major advances of the past 12 months include age-related biomarker cutoff levels for optimising pulmonary embolism diagnosis and risk stratification; detection of (isolated) subsegmental pulmonary embolism by computed tomographic pulmonary angi…

Pulmonary and Respiratory MedicineVena cava filtersmedicine.medical_specialtybusiness.industryMEDLINEAnticoagulantsDiseasemedicine.diseaseRisk AssessmentPulmonary embolismFibrinolytic AgentsmedicinePulmonary angiographyBiomarker (medicine)HumansThrombolytic TherapyRisk assessmentbusinessIntensive care medicinePulmonary EmbolismDisease burdenBiomarkersCurrent opinion in pulmonary medicine
researchProduct

Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale

2020

The diagnostic strategy for chronic thromboembolic pulmonary hypertension (CTEPH) is composed of two components required for a diagnosis of CTEPH: the presence of chronic pulmonary embolism and an elevated pulmonary artery pressure. The current guidelines require that ventilation–perfusion single-photon emission computed tomography (VQ-SPECT) is used for the first step diagnosis of chronic pulmonary embolism. However, VQ-SPECT exposes patients to ionizing radiation in a radiation sensitive population. The prospective, multicenter, comparative phase III diagnostic trial CTEPH diagnosis Europe - MRI (CHANGE-MRI, ClinicalTrials.gov identifier NCT02791282) aims to demonstrate whether functional…

VQ-SPECT0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtypulmonary embolismElevated pulmonary artery pressurePHCTEPHPopulationCardiovascular Medicine030204 cardiovascular system & hematologyMri ; Vq-spect ; Cteph ; Ph ; Pulmonary Embolism ; Diagnostic Strategydiagnostic strategyStudy Protocol03 medical and health sciences0302 clinical medicinemedicine.arteryPulmonary angiographyMedicineeducationeducation.field_of_studymedicine.diagnostic_testbusiness.industryDiagnostic TrialGold standard (test)medicine.disease3. Good healthPulmonary embolism030104 developmental biologylcsh:RC666-701Pulmonary arteryRadiologyCardiology and Cardiovascular MedicinebusinessEmission computed tomographyMRIFrontiers in Cardiovascular Medicine
researchProduct

Update on diagnostic strategies of pulmonary embolism

1999

Acute pulmonary embolism is a frequent disease with non-specific findings, high mortality, and multiple therapeutic options. A definitive diagnosis must be established by accurate, non-invasive, easily performed, cost-effective, and widely available imaging modalities. Conventional diagnostic strategies have relied on ventilation-perfusion scintigraphy complemented by venous imaging. If the results are inconclusive, pulmonary angiography, which is regarded as the gold standard, is to be performed. Recently, marked improvements in CT and MRI and shortcomings of scintigraphy led to an update of the diagnostic strategy. Spiral CT is successfully employed as a second-line procedure to clarify i…

medicine.medical_specialtyHypertension PulmonaryContrast MediaPulmonary ArteryScintigraphyDiagnosis DifferentialPredictive Value of TestsmedicinePulmonary angiographyHumansRadiology Nuclear Medicine and imagingNeuroradiologymedicine.diagnostic_testbusiness.industryReproducibility of ResultsInterventional radiologySequelaGeneral MedicineGold standard (test)medicine.diseasePulmonary embolismEchocardiographyInjections IntravenousAngiographyRadiologyPulmonary EmbolismTomography X-Ray ComputedbusinessMagnetic Resonance AngiographyTomography Emission-ComputedEuropean Radiology
researchProduct

Surgical treatment of chronic thromboembolic pulmonary hypertension.

2006

Chronic thromboembolic pulmonary hypertension is a commonly overlooked cause of physical incapacity and dyspnoea, with a higher incidence than is generally appreciated and a poor prognosis. The diagnosis can be suspected based on echocardiographic examinations and ventilation perfusion scanning of the lung. Pulmonary angiography still remains the gold standard for the diagnosis of thromboembolic pulmonary hypertension and the assessment of operability. Pulmonary endarterectomy is a complex surgical procedure, which provides permanent relief of thromboembolic pulmonary hypertension and cure for most of the patients. The operation resembles a true endarterectomy of the pulmonary artery branch…

medicine.medical_specialtyLungbusiness.industrymedicine.medical_treatmentHypertension PulmonaryExtracorporeal circulationGold standardGeneral Medicinemedicine.anatomical_structureQuality of lifeInternal medicinemedicine.arteryThromboembolismPulmonary arteryCirculatory systemChronic DiseasePulmonary angiographymedicineCardiologyAnimalsHumansbusinessPulmonary EmbolismEndarterectomyLung TransplantationSwiss medical weekly
researchProduct

Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism.

1980

Eighteen patients with acute pulmonary embolism were studied with right heart catheterization and M mode echocardiography. No patient had evidence of preexisting cardiopulmonary disease; pulmonary embolism was documented with pulmonary angiography. The mean pulmonary arterial pressure correlated with the angiographic severity index of embolic obstruction (r = 0.61, p 2 , p 2 ) and in 5 patients with acute pulmonary embolism and a mean normal pulmonary arterial pressure (10.9 ± 0.4 mm/m 2 ). For all measurements the index size of the right pulmonary artery correlated with the mean pulmonary arterial pressure (r = 0.84, p

medicine.medical_specialtyM Mode Echocardiographybusiness.industryHeart VentriclesHypertension PulmonaryBlood PressurePulmonary arterial pressureMiddle AgedPulmonary Arterymedicine.diseaseRight pulmonary arteryPulmonary hypertensionPulmonary embolismEchocardiographyInternal medicineAcute DiseasePulmonary angiographyCardiologyMedicineHumansCardiology and Cardiovascular MedicinebusinessPulmonary wedge pressurePulmonary EmbolismCardiopulmonary diseaseThe American journal of cardiology
researchProduct

Response to ‘Detecting right ventricular dysfunction in patients diagnosed with low-risk pulmonary embolism: is routine computed tomographic pulmonar…

2019

medicine.medical_specialtyRivaroxabanmedicine.diagnostic_testmedicine.drug_mechanism_of_actionbusiness.industryFactor Xa Inhibitormedicine.diseaseRight ventricular dysfunctionPulmonary embolismComputed tomographicAngiographyPulmonary angiographyMedicineIn patientRadiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct